Jade Biosciences (JBIO) Total Current Liabilities (2020 - 2026)
Jade Biosciences (JBIO) posted Total Current Liabilities of $22.3 million for Q1 2026, up 34.78% on a QoQ basis from $16.5 million in Q4 2025, and up 822.3% year-over-year from $2.4 million in Q1 2025.
Jade Biosciences (JBIO) Total Current Liabilities (2020 - 2026) Analysis & Trends
Jade Biosciences' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $22.3 million for Q1 2026.
- Quarterly Total Current Liabilities rose 822.3% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (up 822.3% YoY) and the FY2025 annual result came in at $16.5 million, up 37.87% from the prior year.
- Total Current Liabilities was $22.3 million for Q1 2026 at Jade Biosciences, up from $16.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $22.4 million in Q3 2025 and bottomed at $2.4 million in Q1 2025.
- A 5-year average of $13.0 million and a median of $13.3 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2025 — Total Current Liabilities slumped 84.42% — and 2026, when it jumped 822.3%.
- Jade Biosciences' Total Current Liabilities stood at $7.8 million in 2022, then jumped by 126.64% to $17.6 million in 2023, then tumbled by 31.98% to $12.0 million in 2024, then soared by 37.87% to $16.5 million in 2025, then jumped by 34.78% to $22.3 million in 2026.
- Business Quant data shows JBIO's Total Current Liabilities at $22.3 million in Q1 2026, $16.5 million in Q4 2025, and $22.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 22.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.29 Mn |
| Dec 31, 2025 | 16.54 Mn |
| Sep 30, 2025 | 22.36 Mn |
| Jun 30, 2025 | 21.62 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 10.32 Mn |
| Jun 30, 2024 | 17.02 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Dec 31, 2023 | 17.64 Mn |
| Sep 30, 2023 | 14.73 Mn |
| Jun 30, 2023 | 13.28 Mn |
| Mar 31, 2023 | 10.64 Mn |
| Dec 31, 2022 | 7.78 Mn |
| Sep 30, 2022 | 7.71 Mn |
| Jun 30, 2022 | 3.76 Mn |
| Mar 31, 2022 | 4.70 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | 3.83 Mn |
| Jun 30, 2021 | 4.19 Mn |